Targeting cytohesin-1 suppresses acute myeloid leukemia progression and overcomes resistance to ABT-199
Authors:
- 29 August 2023
- journal article
- research article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 45 (1) , 180-192
Abstract
Adhesion molecules play essential roles in the homeostatic regulation and malignant transformation of hematopoietic cells. The dysregulated expression of adhesion molecules in leukemic cells accelerates disease progression and the development of drug resistance. Thus, targeting adhesion molecules represents an attractive anti-leukemic therapeutic strategy. In this study, we investigated the prognostic role and functional significance of cytohesin-1 (CYTH1) in acute myeloid leukemia (AML). Analysis of AML patient data from the GEPIA and BloodSpot databases revealed that CYTH1 was significantly overexpressed in AML and independently correlated with prognosis. Functional assays using AML cell lines and an AML xenograft mouse model confirmed that CYTH1 depletion significantly inhibited the adhesion, migration, homing, and engraftment of leukemic cells, delaying disease progression and prolonging animal survival. The CYTH1 inhibitor SecinH3 exerted in vitro and in vivo anti-leukemic effects by disrupting leukemic adhesion and survival programs. In line with the CYTH1 knockdown results, targeting CYTH1 by SecinH3 suppressed integrin-associated adhesion signaling by reducing ITGB2 expression. SecinH3 treatment efficiently induced the apoptosis and inhibited the growth of a panel of AML cell lines (MOLM-13, MV4-11 and THP-1) with mixed-lineage leukemia gene rearrangement, partly by reducing the expression of the anti-apoptotic protein MCL1. Moreover, we showed that SecinH3 synergized with the BCL2-selective inhibitor ABT-199 (venetoclax) to inhibit the proliferation and promote the apoptosis of ABT-199-resistant leukemic cells. Taken together, our results not only shed light on the role of CYTH1 in cell-adhesion-mediated leukemogenesis but also propose a novel combination treatment strategy for AML.Keywords
This publication has 51 references indexed in Scilit:
- Role of CXCR4 in the Pathogenesis of Acute Myeloid LeukemiaTheranostics, 2013
- Overexpression of amyloid precursor protein in acute myeloid leukemia enhances extramedullary infiltration by MMP-2Tumor Biology, 2012
- Anti-Proliferative Effect of Cytohesin Inhibition in Gefitinib-Resistant Lung Cancer CellsPLOS ONE, 2012
- How I treat extramedullary acute myeloid leukemiaBlood, 2011
- Cytohesin-1 regulates human blood neutrophil adhesion to endothelial cells through β2 integrin activationMolecular Immunology, 2011
- Cytohesin-1 controls the activation of RhoA and modulates integrin-dependent adhesion and migration of dendritic cellsBlood, 2009
- Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistanceNature, 2006
- α3β1 integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: a novel mechanism of integrin-mediated MMP gene expressionJournal of Cell Science, 2005
- AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML casesBlood, 2003
- Expression of adhesion molecules on acute leukemic blast cells and sensitivity to normal LAK activityAnnals of Hematology, 1993